Literature DB >> 9371619

Transient, nonlethal expression of genes in vertebrate cells by recombinant entomopoxviruses.

Y Li1, R L Hall, R W Moyer.   

Abstract

The group B entomopoxvirus (EPV) from Amsacta moorei (AmEPV) productively infects only insect cells. A series of AmEPV-lacZ recombinants was constructed in which the lacZ gene was regulated by either late (the AmEPV spheroidin or the cowpox virus A-type inclusion [ATI]) or early (the AmEPV esp [early strong promoter; derived from a 42-kDa AmEPV protein] or the Melolontha melolontha EPV fusolin, fus) virus promoters. When the AmEPV recombinants were used to infect vertebrate cells, beta-galactosidase expression occurred (in >30% of the cells) when lacZ was regulated by either the fus or esp early promoters but not when lacZ was regulated by the late promoters (spheroidin or ATI). Therefore, AmEPV enters vertebrate cells and undergoes at least a partial uncoating and early, but not late, viral genes are expressed. Neither viral DNA synthesis nor cytopathic effects were observed under any infection conditions. When an AmEPV recombinant virus containing the Aequorea victoria green fluorescent protein gene (gfp) under the control of the esp promoter was used to infect vertebrate cells at a low multiplicity of infection, single fluorescent cells resulted, which continued to divide over a period of several days, ultimately forming fluorescent cell clusters, suggesting that vertebrate cells survive the infection and continue to grow. Therefore, AmEPV may prove to be a highly efficient, nontoxic method of gene delivery into vertebrate cells for transient gene expression.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9371619      PMCID: PMC230263     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  25 in total

1.  A recombinant canarypox virus protects rabbits against a lethal rabbit hemorrhagic disease virus (RHDV) challenge.

Authors:  L Fischer; F X Le Gros; P W Mason; E Paoletti
Journal:  Vaccine       Date:  1997-01       Impact factor: 3.641

2.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

3.  Tracking and quantitation of retroviral-mediated transfer using a completely humanized, red-shifted green fluorescent protein gene.

Authors:  R R Muldoon; J P Levy; S R Kain; P A Kitts; C J Link
Journal:  Biotechniques       Date:  1997-01       Impact factor: 1.993

4.  The Amsacta moorei entomopoxvirus spheroidin gene is improperly transcribed in vertebrate poxviruses.

Authors:  R L Hall; Y Li; J Feller; R W Moyer
Journal:  Virology       Date:  1996-10-15       Impact factor: 3.616

5.  Detection of Amsacta moorei entomopoxvirus and vaccinia virus proteins in cell cultures restrictive for poxvirus multiplication.

Authors:  W H Langridge
Journal:  J Invertebr Pathol       Date:  1983-07       Impact factor: 2.841

6.  Isolation and preliminary characterization of temperature-sensitive mutants of vaccinia virus.

Authors:  R C Condit; A Motyczka
Journal:  Virology       Date:  1981-08       Impact factor: 3.616

7.  Effect of canarypox virus (ALVAC)-mediated cytokine expression on murine prostate tumor growth.

Authors:  M Kawakita; G S Rao; J K Ritchey; D K Ornstein; M A Hudson; J Tartaglia; E Paoletti; P A Humphrey; T J Harmon; T L Ratliff
Journal:  J Natl Cancer Inst       Date:  1997-03-19       Impact factor: 13.506

8.  NYVAC-Pf7: a poxvirus-vectored, multiantigen, multistage vaccine candidate for Plasmodium falciparum malaria.

Authors:  J A Tine; D E Lanar; D M Smith; B T Wellde; P Schultheiss; L A Ware; E B Kauffman; R A Wirtz; C De Taisne; G S Hui; S P Chang; P Church; M R Hollingdale; D C Kaslow; S Hoffman; K P Guito; W R Ballou; J C Sadoff; E Paoletti
Journal:  Infect Immun       Date:  1996-09       Impact factor: 3.441

9.  Infectious poxvirus vectors have capacity for at least 25 000 base pairs of foreign DNA.

Authors:  G L Smith; B Moss
Journal:  Gene       Date:  1983-11       Impact factor: 3.688

10.  The assay, purification and properties of vaccinia virus-induced uncoating protein.

Authors:  C B Pedley; R J Cooper
Journal:  J Gen Virol       Date:  1987-04       Impact factor: 3.891

View more
  7 in total

Review 1.  Biological transmission of arboviruses: reexamination of and new insights into components, mechanisms, and unique traits as well as their evolutionary trends.

Authors:  Goro Kuno; Gwong-Jen J Chang
Journal:  Clin Microbiol Rev       Date:  2005-10       Impact factor: 26.132

2.  Functional analysis of the inhibitor of apoptosis (iap) gene carried by the entomopoxvirus of Amsacta moorei.

Authors:  Qianjun Li; Peter Liston; Richard W Moyer
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

3.  Vaccinia virus activation of CCR5 invokes tyrosine phosphorylation signaling events that support virus replication.

Authors:  Ramtin Rahbar; Thomas T Murooka; Anna A Hinek; Carole L Galligan; Antonella Sassano; Celeste Yu; Kishore Srivastava; Leonidas C Platanias; Eleanor N Fish
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

4.  Yaba-like disease virus: an alternative replicating poxvirus vector for cancer gene therapy.

Authors:  Y Hu; J Lee; J A McCart; H Xu; B Moss; H R Alexander; D L Bartlett
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

5.  The genome of Melanoplus sanguinipes entomopoxvirus.

Authors:  C L Afonso; E R Tulman; Z Lu; E Oma; G F Kutish; D L Rock
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

6.  Drosophila S2 cells are non-permissive for vaccinia virus DNA replication following entry via low pH-dependent endocytosis and early transcription.

Authors:  Zain Bengali; P S Satheshkumar; Zhilong Yang; Andrea S Weisberg; Nir Paran; Bernard Moss
Journal:  PLoS One       Date:  2011-02-15       Impact factor: 3.240

7.  RIG-I mediates the co-induction of tumor necrosis factor and type I interferon elicited by myxoma virus in primary human macrophages.

Authors:  Fuan Wang; Xiujuan Gao; John W Barrett; Qing Shao; Eric Bartee; Mohamed R Mohamed; Masmudur Rahman; Steve Werden; Timothy Irvine; Jingxin Cao; Gregory A Dekaban; Grant McFadden
Journal:  PLoS Pathog       Date:  2008-07-11       Impact factor: 6.823

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.